Advertisement

Breast Cancer Research and Treatment

, Volume 169, Issue 1, pp 115–123 | Cite as

Associations of coffee consumption and caffeine intake with mammographic breast density

  • Lusine Yaghjyan
  • Graham Colditz
  • Bernard Rosner
  • Aleksandra Gasparova
  • Rulla M. Tamimi
Epidemiology

Abstract

Purpose

Previous studies suggest that coffee and caffeine intake may be associated with reduced breast cancer risk. We investigated the association of coffee and caffeine intake with mammographic breast density by woman’s menopausal status and, in postmenopausal women, by hormone therapy (HT).

Methods

This study included 4130 cancer-free women within the Nurses’ Health Study and Nurses’ Health Study II cohorts. Percent breast density (PD) was measured from digitized film mammograms using a computer-assisted thresholding technique and square root-transformed for the analysis. Average cumulative coffee/caffeine consumption was calculated using data from all food frequency questionnaires preceding the mammogram date. Information regarding breast cancer risk factors was obtained from questionnaires closest to the mammogram date. We used generalized linear regression to quantify associations of regular, decaffeinated, and total coffee, and energy-adjusted caffeine intake with percent density.

Results

In multivariable analyses, decaffeinated coffee was positively associated with PD in premenopausal women (2+ cups/day: β = 0.23, p trend = 0.03). In postmenopausal women, decaffeinated and total coffee were inversely associated with PD (decaffeinated 2+ cups/day: β = − 0.24, p trend = 0.04; total 4+ cups/day: β = − 0.16, p trend = 0.02). Interaction of decaffeinated coffee with menopausal status was significant (p-interaction < 0.001). Among current HT users, regular coffee and caffeine were inversely associated with PD (regular coffee 4+ cups/day: β = − 0.29, p trend = 0.01; caffeine 4th vs. 1st quartile: β = − 0.32, p trend = 0.01). Among past users, decaffeinated coffee was inversely associated with PD (2+ cups/day β = − 0.70, p trend = 0.02).

Conclusions

Associations of decaffeinated coffee with percent density differ by woman’s menopausal status. Associations of regular coffee and caffeine with percent density may differ by HT status.

Keywords

Caffeine Coffee intake Breast density Postmenopausal hormone therapy 

Notes

Acknowledgements

This work was supported by the National Cancer Institute at the National Institutes of Health [Grant Numbers CA131332, CA087969, CA175080 to R.M.T., UM1 CA186107 to M.S., UM1 CA176726 to W.W]; Avon Foundation for Women; Susan G. Komen for the Cure®; and Breast Cancer Research Foundation.

Compliance with ethical standards

Conflict of interests

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

This study was approved by the Institutional Review Board at the Brigham and Women’s Hospital. Consent was obtained or implied by return of questionnaires.

References

  1. 1.
    McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 15(6):1159–1169CrossRefGoogle Scholar
  2. 2.
    Tamimi RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99(15):1178–1187CrossRefPubMedGoogle Scholar
  3. 3.
    Baker JA, Beehler GP, Sawant AC, Jayaprakash V, McCann SE, Moysich KB (2006) Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 136(1):166–171CrossRefPubMedGoogle Scholar
  4. 4.
    Lowcock EC, Cotterchio M, Anderson LN, Boucher BA, El-Sohemy A (2013) High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype. Nutr Cancer 65(3):398–409CrossRefPubMedGoogle Scholar
  5. 5.
    Oh JK, Sandin S, Strom P, Lof M, Adami HO, Weiderpass E (2015) Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. Int J Cancer 137(8):1979–1989CrossRefPubMedGoogle Scholar
  6. 6.
    Bhoo-Pathy N, Peeters PHM, Uiterwaal CSPM, Bueno-de-Mesquita HB, Bulgiba AM, Bech BH, Overvad K, Tjønneland A, Olsen A, Clavel-Chapelon F, Fagherazzi G, Perquier F, Teucher B, Kaaks R, Schütze M, Boeing H, Lagiou P, Orfanos P, Trichopoulou A, Agnoli C, Mattiello A, Palli D, Tumino R, Sacerdote C, van Duijnhoven FJB, Braaten T, Lund E, Skeie G, Redondo M-L, Buckland G, Pérez MJS, Chirlaque M-D, Ardanaz E, Amiano P, Wirfält E, Wallström P, Johansson I, Nilsson LM, Khaw K-T, Wareham N, Allen NE, Key TJ, Rinaldi S, Romieu I, Gallo V, Riboli E, van Gils CH (2015) Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Breast Cancer Res 17(1):15CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Sisti JS, Hankinson SE, Caporaso NE, Gu F, Tamimi RM, Rosner B, Xu X, Ziegler R, Eliassen AH (2015) Caffeine, coffee, and tea intake and urinary estrogens and estrogen metabolites in premenopausal women. Cancer Epidemiol Biomark Prev 24(8):1174–1183CrossRefGoogle Scholar
  8. 8.
    Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, Tworoger SS (2009) Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer 115(12):2765–2774CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, Tworoger SS (2009) Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer 115(12):2765–2774CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Halvorsen BL, Carlsen MH, Phillips KM, Bøhn SK, Holte K, Jacobs DR, Blomhoff R (2006) Content of redox-active compounds (i.e., antioxidants) in foods consumed in the United States. Am J Clin Nutr 84(1):95–135CrossRefPubMedGoogle Scholar
  11. 11.
    Rahmioglu N, Heaton J, Clement G, Gill R, Surdulescu G, Zlobecka K, Hodgkiss D, Ma Y, Hider RC, Smith NW, Ahmadi KR (2011) Genetic epidemiology of induced CYP3A4 activity. Pharmacogenet Genomics 21(10):642–651CrossRefPubMedGoogle Scholar
  12. 12.
    Lee WJ, Zhu BT (2006) Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 27(2):269–277CrossRefPubMedGoogle Scholar
  13. 13.
    Pozner J, Papatestas AE, Fagerstrom R, Schwartz I, Saevitz J, Feinberg M, Aufses AH Jr (1986) Association of tumor differentiation with caffeine and coffee intake in women with breast cancer. Surgery 100(3):482–488PubMedGoogle Scholar
  14. 14.
    Boyd NF, Greenberg C, Lockwood G, Little L, Martin L, Byng J, Yaffe M, Tritchler D (1997) Effects at 2 years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. J Natl Cancer Inst 89(7):488–496CrossRefPubMedGoogle Scholar
  15. 15.
    Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA (2000) Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomark Prev 9(2):151–160Google Scholar
  16. 16.
    Tseng M, Vierkant RA, Kushi LH, Sellers TA, Vachon CM (2008) Dietary patterns and breast density in the Minnesota breast cancer family study. Cancer Causes Control 19(5):481–489CrossRefPubMedGoogle Scholar
  17. 17.
    Takata Y, Maskarinec G, Park SY, Murphy SP, Wilkens LR, Kolonel LN (2007) Mammographic density and dietary patterns: the multiethnic cohort. Eur J Cancer Prev 16(5):409–414CrossRefPubMedGoogle Scholar
  18. 18.
    Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA (2000) Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomark 9(2):151–160Google Scholar
  19. 19.
    Conner P, Svane G, Azavedo E, Soderqvist G, Carlstrom K, Graser T, Walter F, von Schoultz B (2004) Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy. Fertil Steril 81(6):1617–1623CrossRefPubMedGoogle Scholar
  20. 20.
    Greendale GA, Palla SL, Ursin G, Laughlin GA, Crandall C, Pike MC, Reboussin BA (2005) The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the postmenopausal estrogen/progestin interventions mammographic density study. Am J Epidemiol 162(9):826–834CrossRefPubMedGoogle Scholar
  21. 21.
    Pettersen PC, Raundahl J, Loog M, Nielsen M, Tanko LB, Christiansen C (2008) Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist- and computer-based analyses of mammograms. Climacteric 11(2):135–143CrossRefPubMedGoogle Scholar
  22. 22.
    Vachon CM, Sellers TA, Vierkant RA, Wu FF, Brandt KR (2002) Case-control study of increased mammographic breast density response to hormone replacement therapy. Cancer Epidemiol Biomark Prev 11(11):1382–1388Google Scholar
  23. 23.
    Colditz GA, Hankinson SE (2005) The nurses’ health study: lifestyle and health among women. Nat Rev Cancer 5(5):388–396CrossRefPubMedGoogle Scholar
  24. 24.
    Tworoger SS, Sluss P, Hankinson SE (2006) Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 66(4):2476–2482CrossRefPubMedGoogle Scholar
  25. 25.
    Bertrand KA, Rosner B, Eliassen AH, Hankinson SE, Rexrode KM, Willett W, Tamimi RM (2015) Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer. Breast Cancer Res Treat 149(2):479–487CrossRefPubMedGoogle Scholar
  26. 26.
    Farvid MS, Cho E, Chen WY, Eliassen AH, Willett WC (2014) Dietary protein sources in early adulthood and breast cancer incidence: prospective cohort study. BMJ 348:g3437CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC (2005) Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses’ health study. Am J Epidemiol 161(7):672–679CrossRefPubMedGoogle Scholar
  28. 28.
    Byng JW, Boyd NF, Little L, Lockwood G, Fishell E, Jong RA, Yaffe MJ (1996) Symmetry of projection in the quantitative analysis of mammographic images. Eur J Cancer Prev 5(5):319–327CrossRefPubMedGoogle Scholar
  29. 29.
    Pettersson A, Hankinson S, Willett W, Lagiou P, Trichopoulos D, Tamimi R (2011) Nondense mammographic area and risk of breast cancer. Breast Cancer Res 13(5):R100CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Bertrand K, Eliassen AH, Hankinson S, Gierach G, Xu X, Rosner B, Ziegler R, Tamimi R (2012) Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women. Breast Cancer Res Treat 136(1):277–287CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, Rosner B, Cramer D, Hennekens CH (1983) Cigarette smoking, relative weight, and menopause. Am J Epidemiol 117(6):651–658CrossRefPubMedGoogle Scholar
  32. 32.
    Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH (1985) A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313(17):1044–1049CrossRefPubMedGoogle Scholar
  33. 33.
    Treur JL, Taylor AE, Ware JJ, McMahon G, Hottenga JJ, Baselmans BML, Willemsen G, Boomsma DI, Munafò MR, Vink JM (2016) Associations between smoking and caffeine consumption in two European cohorts. Addiction 111(6):1059–1068CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Klesges RC, Ray JW, Klesges LM (1994) Caffeinated coffee and tea intake and its relationship to cigarette smoking: an analysis of the second national health and nutrition examination survey (NHANES II). J Subst Abuse 6(4):407–418CrossRefPubMedGoogle Scholar
  35. 35.
    Treur JL, Taylor AE, Ware JJ, McMahon G, Hottenga JJ, Baselmans BM, Willemsen G, Boomsma DI, Munafo MR, Vink JM (2016) Associations between smoking and caffeine consumption in two European cohorts. Addiction 111(6):1059–1068CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87(21):1622–1629CrossRefPubMedGoogle Scholar
  37. 37.
    Yaghjyan L, Colditz GA, Rosner B, Tamimi RM (2013) Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to the time since the mammogram. Cancer Epidemiol Biomark Prev 22(6):1110–1117CrossRefGoogle Scholar
  38. 38.
    Hu FB, Rimm E, Smith-Warner SA, Feskanich D, Stampfer MJ, Ascherio A, Sampson L, Willett WC (1999) Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr 69(2):243–249CrossRefPubMedGoogle Scholar
  39. 39.
    Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122(1):51–65CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Epidemiology, College of Public Health and Health Professions and College of MedicineUniversity of FloridaGainessvilleUSA
  2. 2.Department of SurgeryWashington University in St. Louis School of MedicineSt. LouisUSA
  3. 3.Institute for Public Health, Washington University in St. LouisSt. LouisUSA
  4. 4.Channing Division of Network Medicine, Department of MedicineBrigham and Women’s Hospital and Harvard Medical SchoolBostonUSA

Personalised recommendations